Shopping Cart
- Remove All
- Your shopping cart is currently empty
Iladatuzumab vedotin (DCDS-0780A) is an ADC compound targeting CD79b, conjugated with the cytotoxic drug MMAE through a cleavable dipeptide linker mc-val-cit-PABC, used in the study of non-Hodgkin lymphoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $1,970 | In Stock | |
5 mg | $4,280 | In Stock |
Description | Iladatuzumab vedotin (DCDS-0780A) is an ADC compound targeting CD79b, conjugated with the cytotoxic drug MMAE through a cleavable dipeptide linker mc-val-cit-PABC, used in the study of non-Hodgkin lymphoma. |
Alias | DCDS-0780A, DCDS0780A |
Cas No. | 1906205-77-3 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.